ATE551063T1 - Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen - Google Patents

Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen

Info

Publication number
ATE551063T1
ATE551063T1 AT07704583T AT07704583T ATE551063T1 AT E551063 T1 ATE551063 T1 AT E551063T1 AT 07704583 T AT07704583 T AT 07704583T AT 07704583 T AT07704583 T AT 07704583T AT E551063 T1 ATE551063 T1 AT E551063T1
Authority
AT
Austria
Prior art keywords
bifidobacterium longum
inflammation
prophylaxis
treatment
baaa
Prior art date
Application number
AT07704583T
Other languages
English (en)
Inventor
Annick Mercenier
Stephanie Blum-Sperisen
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE551063T1 publication Critical patent/ATE551063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT07704583T 2006-02-15 2007-02-14 Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen ATE551063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06101690 2006-02-15
PCT/EP2007/051448 WO2007093619A1 (en) 2006-02-15 2007-02-14 Use of bifidobacterium longum for the prevention and treatment of inflammation

Publications (1)

Publication Number Publication Date
ATE551063T1 true ATE551063T1 (de) 2012-04-15

Family

ID=36636972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07704583T ATE551063T1 (de) 2006-02-15 2007-02-14 Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen

Country Status (16)

Country Link
US (2) US8916145B2 (de)
EP (1) EP1986669B1 (de)
CN (1) CN101420965B (de)
AT (1) ATE551063T1 (de)
AU (1) AU2007216461B2 (de)
BR (1) BRPI0707937A2 (de)
CA (1) CA2642431A1 (de)
ES (1) ES2381211T3 (de)
MX (1) MX2008010422A (de)
MY (1) MY148872A (de)
PH (1) PH12012500739A1 (de)
PL (1) PL1986669T3 (de)
PT (1) PT1986669E (de)
RU (1) RU2445362C2 (de)
WO (1) WO2007093619A1 (de)
ZA (1) ZA200807879B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP2110028A1 (de) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum und hippocampale BDNF-Expression
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CN102089422B (zh) * 2008-07-11 2013-07-17 科.汉森有限公司 新的益生长双歧杆菌
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
EP2438821B1 (de) * 2008-11-03 2020-01-15 Société des Produits Nestlé S.A. Nährmittel umfassend probiotika und das schlafmuster verbessernd
CA2741942C (en) * 2008-11-11 2018-01-16 Alimentary Health Limited Bifidobacterium longum strain bl1207
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
EP2251022A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Nicht-replizierte Mikroorganismen und deren immunstärkender Effekt
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102905557A (zh) * 2009-08-18 2013-01-30 雀巢产品技术援助有限公司 包含长双歧杆菌菌株并且特别是在婴儿和儿童中减少食物过敏症状的营养组合物
DK2289527T3 (en) * 2009-08-25 2018-04-23 Nestec Sa BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISEASES
EP2308499A1 (de) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) und Gewichtskontrolle
WO2011058536A1 (en) * 2009-11-11 2011-05-19 Alimentary Health Limited A bifidobacterium strain
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
EP2588654B1 (de) 2010-07-02 2019-08-07 The Procter and Gamble Company Vliesstoff enthaltend einen oder mehrere wirkstoffe
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
EP2588655B1 (de) 2010-07-02 2017-11-15 The Procter and Gamble Company Verfahren für die freisetzung eines wirkstoffes
CN103025929B (zh) 2010-07-02 2015-11-25 宝洁公司 包含活性剂的长丝、非织造纤维网和制备它们的方法
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2455092A1 (de) 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Infektionen der oberen Atemwege
PT3366143T (pt) 2011-06-20 2025-01-07 Heinz Co Brands H J Llc Composições e métodos probióticos
EP2768311B2 (de) * 2011-10-18 2025-05-28 Société des Produits Nestlé S.A. Zusammensetzung zur verwendung bei der prävention und/oder behandlung von darmentzündung und/oder bei der erholung nach darmverletzungen und -operationen
CN103820357A (zh) * 2013-12-30 2014-05-28 上海交大昂立股份有限公司 一株长双歧杆菌及其防治食物过敏的功能
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物
BR112018000934B1 (pt) * 2015-08-31 2022-02-01 Société des Produits Nestlé S.A. Usos de bifidobacterium longum para tratar ou prevenir sintomas depressivos
BR112018012022A2 (pt) * 2015-12-14 2018-12-04 Metabogen Ab ?composição, e, método para tratamento ou redução do risco de colestase intra-hepática?
CN110191700A (zh) 2017-01-27 2019-08-30 宝洁公司 可溶性固体结构形式的组合物
EP3573722B1 (de) 2017-01-27 2022-02-23 The Procter & Gamble Company Zusammensetzungen in form von löslichen festen strukturen mitagglomerierten brauseteilchen
CN110494551B (zh) * 2017-01-31 2023-06-16 庆熙大学校产学协力团 新型乳酸菌及其用途
EP3624765A1 (de) 2017-05-16 2020-03-25 The Procter and Gamble Company Konditionierende haarpflegezusammensetzungen in form von löslichen festen strukturen
JP7273824B2 (ja) * 2017-12-29 2023-05-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
CA3114973A1 (en) * 2018-10-02 2020-04-09 Societe Des Produits Nestle S.A. Probiotic combination for treatment of inflammatory-related gastrointestinal disorders
CN113660941A (zh) * 2018-12-21 2021-11-16 雀巢产品有限公司 用于治疗变态反应性疾病的益生菌组合
CN114206307B (zh) 2019-06-28 2024-08-23 宝洁公司 包含阴离子表面活性剂的可溶性固体纤维制品
EP3994163A1 (de) * 2019-07-01 2022-05-11 Société des Produits Nestlé S.A. Serpinherstellung
US20220315883A1 (en) * 2019-07-01 2022-10-06 Societe Des Produits Nestle S.A. Serpin production
CN115867357A (zh) 2020-07-31 2023-03-28 宝洁公司 用于毛发护理的含有球粒的水溶性纤维小袋
KR102343938B1 (ko) * 2020-09-02 2021-12-28 주식회사 비피도 재조합 비피도박테리움 비피덤 bgn4를 포함하는 염증 개선용 조성물
CN112159784A (zh) * 2020-10-29 2021-01-01 佛山市朗芯生物科技有限公司 长双歧杆菌nx-4及其在制备治疗和/或预防过敏性疾病药物中的应用
CH718355A2 (fr) * 2021-02-16 2022-08-31 Nestle Sa Composition et kit pour soulager les symptômes de l'allergie respiratoire.
EP4395730A1 (de) 2021-08-30 2024-07-10 The Procter & Gamble Company Lösliche feste struktur mit ersten und zweiten polymerstrukturierungsmitteln
EP4447893A1 (de) 2021-12-17 2024-10-23 The Procter & Gamble Company Lösliche feste faserige shampooartikel mit salzen
CN114574390B (zh) * 2022-03-09 2024-03-01 江南大学 一株缓解结肠炎的长双歧杆菌婴儿亚种及应用
EP4489719A1 (de) 2022-03-10 2025-01-15 The Procter & Gamble Company Lösliche feste struktur mit ersten und zweiten schichten

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
ES2111625T3 (es) 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
DE69219768T2 (de) 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
EP1034787A1 (de) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
JP2004519241A (ja) * 2001-03-09 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 高齢化に伴う生理的障害を改善し寿命を延ばす組成物
RU2210592C1 (ru) * 2001-12-27 2003-08-20 Российский государственный медицинский университет ШТАММ БАКТЕРИЙ Bifidobacterium longum 58B ДЛЯ ПРИГОТОВЛЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ ДОБАВОК, РЕГУЛИРУЮЩИХ МИКРОФЛОРУ КИШЕЧНИКА У ДЕТЕЙ РАННЕГО ВОЗРАСТА
EP1384483A1 (de) 2002-07-23 2004-01-28 Nestec S.A. Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
ATE421256T1 (de) * 2003-03-13 2009-02-15 Kirin Holdings Kk Probiotische zusammensetzung
PT1638416E (pt) 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch

Also Published As

Publication number Publication date
US9456630B2 (en) 2016-10-04
RU2445362C2 (ru) 2012-03-20
AU2007216461A1 (en) 2007-08-23
MY148872A (en) 2013-06-14
BRPI0707937A2 (pt) 2011-05-10
EP1986669A1 (de) 2008-11-05
WO2007093619A1 (en) 2007-08-23
CN101420965B (zh) 2013-08-07
US8916145B2 (en) 2014-12-23
EP1986669B1 (de) 2012-03-28
PT1986669E (pt) 2012-05-15
CN101420965A (zh) 2009-04-29
PH12012500739A1 (en) 2013-06-17
MX2008010422A (es) 2008-10-27
ES2381211T3 (es) 2012-05-24
CA2642431A1 (en) 2007-08-23
RU2008136876A (ru) 2010-03-20
US20120201785A1 (en) 2012-08-09
PL1986669T3 (pl) 2012-09-28
ZA200807879B (en) 2009-12-30
AU2007216461B2 (en) 2012-08-30
US20090274661A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
JO2576B1 (en) Antibodies
IN2012DN01638A (de)
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
IN2012DN00624A (de)
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
MY147247A (en) Organic compounds and their uses
MA33810B1 (fr) Compositions pour traiter les nausées et vomissements à médiation centrale
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
MY150931A (en) Substituted oxazolidinones and their use
EA201200428A1 (ru) Композиция и способ для лечения ожирения
MY158310A (en) Prevention and treatment of allergic diarrhoea
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2009050677A3 (fr) Utilisation de bacteries lactiques pour la prevention et/ou le traitement de pathologies cutanees
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
IL194353A0 (en) Lysobactin amides
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
NZ596218A (en) Bssl antagonists for treatment of inflammatory diseases